Sunday, October 24, 2021
- Advertisement -spot_img



Phase-3 trial of Bharat Biotech’s Covaxin commences in AIIMS

The Hyderabad-based firm, while applying for phase-three trial, stated that the vaccine was well-tolerated in all dose groups and no serious adverse events have been reported.

Haryana Health Minister Anil Vij administered trial dose of Covaxin

He had offered to be the first volunteer for the third phase trial of Covaxin, which started in the state today.

Phase 3 trial of Covaxin to begin in Haryana on Nov 20

Bharat Biotech had on Monday said the Phase 3 trial of Covaxin will involve 26,000 volunteers across 25 centres in India and is being conducted in partnership with the ICMR.

Hyderabad-based Bharat Biotech starts phase III trials for Covaxin

The phase III trials will involve 26,000 volunteers across 25 centres in India, being conducted in partnership with ICMR

‘Covid-19 vaccine being developed in record time’

Hyderabad: The Covid-19 vaccine development is happening at a much faster pace when compared to other vaccines and it is pushing the innovation and...

3rd phase human trial of COVID vaccine to commence in Bhubaneswar soon

IMS and SUM Hospital is among the 21 medical institutes selected across the country by the Indian Council for Medical Research (ICMR) where the third phase trial would be conducted.

Drugs Controller General of India nod for Covaxin phase 3 trials

The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech. The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech’s BSL-3 (Bio-Safety Level 3)

Bharat Biotech’s Covaxin to boost immune response with ViroVax adjuvant  

Hyderabad-headquartered company is currently conducting Phase II human trials of Covaxin after receiving Drug Controller General of India nod

Bharat Biotech’s Covaxin gets nod for phase II trials

Among several hospitals across the country, the city-based NIMS was also selected to take part in phase I clinical trials of Covaxin, which concluded recently.

Preparations on for second phase of human clinical trial of ‘Covaxin’ vaccine

The blood samples collected from the volunteers who received the vaccine were to ascertain how effective the vaccine was in terms of the level of antibodies developed.

Advantage Hyderabad

Of the 6 Indian biotech firms engaged in vaccine development, four are in Hyderabad, signifying the importance of the city in this critical area

Human clinical trial of ‘Covaxin’ begins in Odisha

Bhubaneswar: The human clinical trial of India's first possible anti-Covid vaccine 'Covaxin' began at an institute here on Monday, an official said. The human trial...

Human trials of Covaxin begin at Goa’s Redkar Hospital: Pramod Sawant

Panaji: Goa Chief Minister Pramod Sawant has said that the human trials of coronavirus vaccine have begun at the state's Redkar Hospital and congratulated...

Insulate science from politics

Cutting red tape should not mean creating a situation where hospital ethics committees are put under duress and outcomes are fudged

ICMR aims to launch indigenous COVID-19 vaccine by Aug 15 

Twelve clinical trial sites have been identified at present and the apex health research body has asked the medical institutions and principal investigators to ensure that the subject enrolment is initiated no later than July 7.

Indigenous vaccine offers hope

India needs to up its game and create an ecosystem where it can play a big role in R&D, manufacturing

Bharat Biotech’s Covid vaccine gets DCGI nod for clinical trials

Having completed pre-clinical studies, human clinical trials are scheduled to start across India in July

Latest news

- Advertisement -spot_img
Telangana Today